NO933611L - Anti-tumor- og anti-psoriatiske midler - Google Patents
Anti-tumor- og anti-psoriatiske midlerInfo
- Publication number
- NO933611L NO933611L NO93933611A NO933611A NO933611L NO 933611 L NO933611 L NO 933611L NO 93933611 A NO93933611 A NO 93933611A NO 933611 A NO933611 A NO 933611A NO 933611 L NO933611 L NO 933611L
- Authority
- NO
- Norway
- Prior art keywords
- tumor
- psoriatic agents
- compounds
- agents
- psoriatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/044—Pyrrole radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68377091A | 1991-04-11 | 1991-04-11 | |
PCT/US1992/002661 WO1992018507A1 (en) | 1991-04-11 | 1992-04-09 | Anti-tumor and anti-psoriatic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
NO933611D0 NO933611D0 (no) | 1993-10-08 |
NO933611L true NO933611L (no) | 1993-10-08 |
Family
ID=24745378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO93933611A NO933611L (no) | 1991-04-11 | 1993-10-08 | Anti-tumor- og anti-psoriatiske midler |
Country Status (14)
Country | Link |
---|---|
EP (2) | EP0508792A1 (xx) |
JP (1) | JPH06503837A (xx) |
CA (1) | CA2108146A1 (xx) |
CZ (1) | CZ213693A3 (xx) |
FI (1) | FI934461A0 (xx) |
HU (1) | HUT70187A (xx) |
IE (1) | IE921148A1 (xx) |
IL (1) | IL101554A0 (xx) |
MX (1) | MX9201643A (xx) |
NO (1) | NO933611L (xx) |
NZ (1) | NZ242294A (xx) |
SK (1) | SK108293A3 (xx) |
TW (1) | TW214553B (xx) |
WO (1) | WO1992018507A1 (xx) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69326388T2 (de) * | 1992-06-22 | 1999-12-30 | Kyowa Hakko Kogyo Co., Ltd. | Verfahren zur Herstellung von Staurosporin-Derivaten |
US5589472A (en) * | 1992-09-25 | 1996-12-31 | Vice; Susan F. | Diindolo compounds and pharmaceutical compositions containing them |
US5624949A (en) * | 1993-12-07 | 1997-04-29 | Eli Lilly And Company | Protein kinase C inhibitors |
US5843935A (en) * | 1993-12-07 | 1998-12-01 | Eli Lilly And Company | Protein kinase C inhibitors |
ATE204579T1 (de) * | 1993-12-07 | 2001-09-15 | Lilly Co Eli | Proteinkinase c-inhibitoren |
US5723456A (en) * | 1993-12-07 | 1998-03-03 | Eli Lilly & Company | Therapeutic treatment for cardiovascular diseases |
AU1911095A (en) * | 1994-02-18 | 1995-09-04 | Cephalon, Inc. | Aqueous indolocarbazole solutions |
WO1997005140A1 (en) * | 1995-07-31 | 1997-02-13 | Novartis Ag | Trindene compounds |
US20040037828A1 (en) | 2002-07-09 | 2004-02-26 | Bar-Ilan University | Methods and pharmaceutical compositions for healing wounds |
FR2826653B1 (fr) | 2001-06-29 | 2005-10-14 | Servier Lab | Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
TW201041580A (en) | 2001-09-27 | 2010-12-01 | Alcon Inc | Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
RU2358753C2 (ru) | 2003-08-07 | 2009-06-20 | Хилор Лтд. | Фармацевтические композиции и способы для ускорения заживления ран |
ZA200802546B (en) | 2005-08-29 | 2009-10-28 | Healor Ltd | Methods and compositions for prvention and treatment of diabetic and aged skin |
EP2181999A1 (en) | 2008-11-03 | 2010-05-05 | Zentiva, A.S. | Method of manufacturing ruboxistarin |
RU2012134041A (ru) | 2010-01-11 | 2014-02-20 | Хилор Лтд. | Способ лечения воспалительного заболевания и расстройства |
JP2017524739A (ja) | 2014-07-17 | 2017-08-31 | アンセルムInserm | 神経筋接合部関連疾患の処置方法 |
WO2016207366A1 (en) | 2015-06-26 | 2016-12-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of viral infections |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3752123T2 (de) * | 1987-03-09 | 1998-05-14 | Kyowa Hakko Kogyo Kk | Derivate des physiologisch aktiven mittels k-252 |
DE3924538A1 (de) * | 1989-07-25 | 1991-01-31 | Goedecke Ag | Indolocarbazol und dessen verwendung |
-
1992
- 1992-04-09 JP JP4510240A patent/JPH06503837A/ja active Pending
- 1992-04-09 TW TW081102729A patent/TW214553B/zh active
- 1992-04-09 IL IL101554A patent/IL101554A0/xx unknown
- 1992-04-09 SK SK1082-93A patent/SK108293A3/sk unknown
- 1992-04-09 CA CA002108146A patent/CA2108146A1/en not_active Abandoned
- 1992-04-09 NZ NZ242294A patent/NZ242294A/en unknown
- 1992-04-09 EP EP92303187A patent/EP0508792A1/en not_active Withdrawn
- 1992-04-09 HU HU9302869A patent/HUT70187A/hu unknown
- 1992-04-09 EP EP92917468A patent/EP0580812A1/en active Pending
- 1992-04-09 CZ CS932136A patent/CZ213693A3/cs unknown
- 1992-04-09 MX MX9201643A patent/MX9201643A/es unknown
- 1992-04-09 WO PCT/US1992/002661 patent/WO1992018507A1/en not_active Application Discontinuation
- 1992-04-10 IE IE114892A patent/IE921148A1/en unknown
-
1993
- 1993-10-08 NO NO93933611A patent/NO933611L/no unknown
- 1993-10-11 FI FI934461A patent/FI934461A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ242294A (en) | 1993-07-27 |
FI934461A (fi) | 1993-10-11 |
EP0508792A1 (en) | 1992-10-14 |
IL101554A0 (en) | 1992-12-30 |
AU646163B2 (en) | 1994-02-10 |
CA2108146A1 (en) | 1992-10-12 |
NO933611D0 (no) | 1993-10-08 |
EP0580812A1 (en) | 1994-02-02 |
CZ213693A3 (en) | 1994-05-18 |
WO1992018507A1 (en) | 1992-10-29 |
IE921148A1 (en) | 1992-10-21 |
SK108293A3 (en) | 1994-09-07 |
MX9201643A (es) | 1992-10-01 |
AU1798292A (en) | 1992-11-17 |
JPH06503837A (ja) | 1994-04-28 |
HU9302869D0 (en) | 1993-12-28 |
FI934461A0 (fi) | 1993-10-11 |
TW214553B (xx) | 1993-10-11 |
HUT70187A (en) | 1995-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO933611L (no) | Anti-tumor- og anti-psoriatiske midler | |
FI943142A0 (fi) | Amidi- ja ureajohdannaiset, joilla on veren korkeita kolesteroliarvoja vastustava vaikutus, niiden valmistus ja terapeuttiset käytöt | |
DK0564924T3 (da) | 2-Oxoethylderivater som immunosuppressiva | |
NO996108L (no) | 9-oksinerytromycinderivater | |
ES2082780T3 (es) | Derivados de acido bisfosfonico heterociclicos. | |
SE8900192D0 (sv) | Dideoxididehydrokarbocykliska nukleosider | |
NO982987L (no) | Amidinoproteasehemmere | |
JO1704B1 (en) | New potent compounds | |
ES2052897T3 (es) | Nucleosidos didesoxidideshidrocarbociclicos. | |
NO178968C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive aminopyrimidin-karboksamidderivater | |
NO923721D0 (no) | 4-desoksy-4-epipodophyllotoxin-derivat eller farmasoeytiskakseptabelt salt derav | |
AU614204B2 (en) | 16-hydroxymethyl amphotericin b derivatives | |
ATE213241T1 (de) | Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase | |
MX9804828A (es) | Benzotiazolona etanaminas biologicamente activas. | |
MY110004A (en) | Biologically active ureido derivatives useful as antimetastatic agents. | |
DE69828390D1 (de) | Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung | |
MX9206930A (es) | Nuevos compuestos | |
CA2120229A1 (fr) | Derives de methylpiperazinoazepine, leur preparation et leur utilisation | |
NO974651L (no) | Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose | |
NO174963C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider | |
NO851206L (no) | Fremgangsmaate for fremstilling av terapeutisk virksomme 1,4-dihydropyridiner | |
EP0509098A4 (en) | Ataractic | |
KR970702869A (ko) | 항종양성 인돌로피롤로카르바졸 유도체(antitumor indolopyprolocarbazole derivative) | |
FI921475A0 (fi) | 1,4-dihydro-4-oxo-3-kinolinderivat som selektivt toxiska antibakteriella aemenn hos daeggdjur. | |
ATA262787A (de) | Pharmazeutische verwendung einer 8-chlorobenzothiazepinverbindung |